Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/IIa Gene Transfer Clinical Trial for Juvenile Neuronal Ceroid Lipofuscinosis, Delivering the CLN3 Gene by Self-Complementary AAV9

NCT03770572 is registered in ClinicalTrials.gov with Neela Therapeutics as lead sponsor.

NCT NCT03770572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03770572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/IIa Gene Transfer Clinical Trial for Juvenile Neuronal Ceroid Lipofuscinosis, Delivering the CLN3 Gene by Self-Complementary AAV9
Lead sponsor
Neela Therapeutics
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
November 13, 2018
Completion date
September 30, 2029
Enrollment
7 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

batten disease, cln3